Recent NXL News
- Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th • GlobeNewswire Inc. • 11/01/2024 06:00:00 PM
- Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements • GlobeNewswire Inc. • 11/01/2024 02:34:54 PM
- Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease • GlobeNewswire Inc. • 10/28/2024 12:30:00 PM
- Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA • GlobeNewswire Inc. • 10/22/2024 06:15:00 PM
- New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s Patients • GlobeNewswire Inc. • 10/17/2024 12:30:00 PM
- Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs • GlobeNewswire Inc. • 10/14/2024 12:30:00 PM
- Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment • GlobeNewswire Inc. • 09/05/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 04:59:35 PM
- Veritone and Nuix Combine AI Expertise to Offer Turn-Key Solutions for Growing Volumes of Video and Audio Data • Business Wire • 08/22/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2024 08:25:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 04:34:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 09:29:21 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/29/2024 07:30:09 PM
- Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery • GlobeNewswire Inc. • 07/18/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 09:03:28 PM
- Nexalin Technology Announces Closing of $5.2 Million Public Offering • GlobeNewswire Inc. • 07/01/2024 06:45:00 PM
- Nexalin Technology Announces Pricing of $5.2 Million Public Offering • GlobeNewswire Inc. • 06/28/2024 01:15:00 AM
- Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific Journal • GlobeNewswire Inc. • 06/26/2024 01:00:00 PM
- Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and Dementia • GlobeNewswire Inc. • 06/20/2024 12:30:00 PM
- Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa) • GlobeNewswire Inc. • 06/13/2024 07:00:00 PM
- Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th • GlobeNewswire Inc. • 06/04/2024 12:30:00 PM
- FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device • GlobeNewswire Inc. • 06/03/2024 12:30:00 PM
- Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts • GlobeNewswire Inc. • 05/22/2024 12:30:00 PM
- Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23 • GlobeNewswire Inc. • 05/09/2024 12:30:00 PM
- Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements • GlobeNewswire Inc. • 04/25/2024 02:44:22 PM
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM